Abstract | BACKGROUND: AIMS: To explore the mechanisms of the anti- cancer effect of GABA on QBC939 cells. METHODS: RESULTS: A significant difference was only observed in GABAB receptor expression between cholangiocarcinoma and normal bile tissues. The MTT and Annexin V-FITC/PI assays showed that the antiproliferative and proapoptotic effects of GABA on QBC939 cells could be antagonized by phaclofen and AG490, but not bicuculine. GABA significantly down-regulated p-STAT3 (Tyr705) expression; this action was also antagonized by phaclofen and AG490. GABA also effectively inhibited xenograft tumor growth, and p-STAT3 (Tyr705) expression was significantly decreased in GABA-treated xenograft tumors. CONCLUSIONS:
GABA may inhibit the growth of cholangiocarcinoma QBC939 cells through the GABAB receptor, and the anti- cancer effects may be partly mediated via the JAK/STAT3 pathway.
|
Authors | Qiang Huang, Cheng-Lin Zhu, Chen-Hai Liu, Fang Xie, Kai Zhu, San-Yuan Hu |
Journal | Digestive diseases and sciences
(Dig Dis Sci)
Vol. 58
Issue 3
Pg. 734-43
(Mar 2013)
ISSN: 1573-2568 [Electronic] United States |
PMID | 23007731
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Receptors, GABA-B
- STAT3 Transcription Factor
- gamma-Aminobutyric Acid
- Janus Kinases
|
Topics |
- Animals
- Cell Line, Tumor
- Cholangiocarcinoma
(metabolism, pathology)
- Gene Expression Regulation, Neoplastic
- Humans
- Janus Kinases
(genetics, metabolism)
- Mice
- Mice, Nude
- Neoplasms, Experimental
(metabolism)
- Protein Binding
- Receptors, GABA-B
(genetics, metabolism)
- STAT3 Transcription Factor
(genetics, metabolism)
- gamma-Aminobutyric Acid
(metabolism)
|